These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 32131602)
21. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Pekow JR; Bhan AK; Zheng H; Chung RT Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861 [TBL] [Abstract][Full Text] [Related]
22. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma]. Pár A Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671 [TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364 [TBL] [Abstract][Full Text] [Related]
24. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. Del Poggio P; Olmi S; Ciccarese F; Di Marco M; Rapaccini GL; Benvegnù L; Borzio F; Farinati F; Zoli M; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F; Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1927-33.e2. PubMed ID: 24582947 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection. Aljumah AA; Kuriry H; Faisal N; Alghamdi H Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991 [TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma among cirrhotics--utility of screening and surveillance programs--review article. Opriță R; Diaconescu IB; Lupu G; Lupu A; Cristea B; Bratu MR J Med Life; 2014; 7(4):477-80. PubMed ID: 25713606 [TBL] [Abstract][Full Text] [Related]
28. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416 [TBL] [Abstract][Full Text] [Related]
30. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502 [TBL] [Abstract][Full Text] [Related]
31. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F; Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228 [TBL] [Abstract][Full Text] [Related]
33. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882 [TBL] [Abstract][Full Text] [Related]
34. Seasonal and weekly fluctuations in alcohol use in the Czech Republic. Barták M; Vacek J; Petruželka B; Nejedlá M; Rogalewicz V Cas Lek Cesk; 2023; 162(2-3):48-51. PubMed ID: 37474286 [TBL] [Abstract][Full Text] [Related]
35. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297 [TBL] [Abstract][Full Text] [Related]
36. Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas. Sinn DH; Yi J; Choi MS; Kim YJ; Gwak GY; Lee JH; Koh KC; Paik SW; Yoo BC Hepatogastroenterology; 2015; 62(138):327-32. PubMed ID: 25916058 [TBL] [Abstract][Full Text] [Related]
37. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738 [TBL] [Abstract][Full Text] [Related]
38. Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status. Kim MN; Hwang SG; Kim BK; Park JY; Kim DY; Han KH; Kim SU; Ahn SH Gut Liver; 2019 Mar; 13(2):197-205. PubMed ID: 30602075 [TBL] [Abstract][Full Text] [Related]
39. The Effect of Hepatocellular Carcinoma Surveillance in an Urban Population With Liver Cirrhosis. Nusbaum JD; Smirniotopoulos J; Wright HC; Dash C; Parpia T; Shechtel J; Chang Y; Loffredo C; Shetty K J Clin Gastroenterol; 2015; 49(10):e91-5. PubMed ID: 25751372 [TBL] [Abstract][Full Text] [Related]
40. Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis. Amarapurkar DN; Dharod M; Gautam S; Patel N Trop Gastroenterol; 2013; 34(3):159-63. PubMed ID: 24851525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]